Description
Retatrutide
Retatrutide is a next-generation medication designed for weight loss and metabolic control. It is a triple agonist of the GIP, GLP-1, and glucagon receptors, meaning it acts on multiple hormonal pathways responsible for appetite regulation, glucose metabolism, and energy expenditure.
This combination leads to significant reductions in body weight, improved insulin sensitivity, and better blood sugar control, with potential cardiovascular benefits as well.
Clinical studies show results superior to medications like semaglutide and tirzepatide, with powerful and long-lasting effects. It is administered subcutaneously, typically once per week.
